Table 2.
Exon designation (in genes with a clinical validity of at least moderate) | Evidence used for designation |
---|---|
Clinically significant exon | • Evidence that exon is required for biological function (eg, literature, absence of high frequency LoF variant in general population) |
AND/OR | |
• No alternative splicing | |
Exon of uncertain significance | • No expression data in the literature |
AND | |
• Alternative splicing | |
AND/OR | |
• 1 High-frequency LoF variant in gnomAD (>0.3%) | |
Clinically insignificant exon | • Literature confirms exon is not expressed in tissue of clinical relevance |
AND/OR | |
• >1 High-quality, high-frequency LoF variant in gnomAD (>0.3%) | |
Noncoding exon | • Exon does not code for protein |
gnomAD, Genome Aggregation Database; LoF, loss of function.